These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7031705)

  • 1. [Biochemical and pharmacological aspects of the thrombin inhibitor hirudin].
    Walsmann P; Markwardt F
    Pharmazie; 1981 Oct; 36(10):653-60. PubMed ID: 7031705
    [No Abstract]   [Full Text] [Related]  

  • 2. Hirudin and derivatives as anticoagulant agents.
    Markwardt F
    Thromb Haemost; 1991 Jul; 66(1):141-52. PubMed ID: 1926044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological approaches to thrombin regulation.
    Markwardt F
    Ann N Y Acad Sci; 1986; 485():204-14. PubMed ID: 3551729
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of selective thrombin inhibitors.
    Markwardt F
    Nouv Rev Fr Hematol (1978); 1988; 30(3):161-5. PubMed ID: 3047669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hirudin and other thrombin inhibitors from blood-sucking animals].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):437-45. PubMed ID: 4121337
    [No Abstract]   [Full Text] [Related]  

  • 9. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
    Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches.
    Markwardt F
    Biomed Biochim Acta; 1985; 44(7-8):1007-13. PubMed ID: 3910034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacology of recombinant hirudin].
    Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):841-9. PubMed ID: 2483701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of hirudin from Hirudo medicinalis.
    Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):83-7. PubMed ID: 1771416
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation inhibition caused by selective thrombin blockade with hirudin].
    Klöss T; Lorenz W; Meyer U; Mittmann U; Neugebauer E; Saggau WW
    Chir Forum Exp Klin Forsch; 1978; (1978):143-8. PubMed ID: 752579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors.
    Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V
    J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
    Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
    [No Abstract]   [Full Text] [Related]  

  • 18. The comeback of hirudin--an old-established anticoagulant agent.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):10-23. PubMed ID: 2459000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin structure and function: why thrombin is the primary target for antithrombotics.
    Fenton JW; Ofosu FA; Moon DG; Maraganore JM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):69-75. PubMed ID: 1772999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.